Alison Moore
Förmögenhet: 350 708 $ per 2026-07-31
Förmögenhet: 350 708 $ per 2026-07-31
Alison Moore is President, Chief Executive Officer & Director at Codexis, Inc. since 2025 and Independent Director at Artiva Biotherapeutics, Inc. since 2024.
Former roles include Director at Alliance for Regenerative Medicine from 2022 to 2023, Chief Technical Officer at Allogene Therapeutics, Inc. from 2018 to 2023, Senior Vice President-Process Development at Amgen, Inc. from 2014 to 2018, and Director-Chemistry & Regulatory Affairs at Genentech, Inc. from 2005 to 2006.
Education includes undergraduate and doctorate degrees from The University of Manchester.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
CODEXIS, INC. 0,23 % | 2026-04-20 | 250 506 ( 0,23 % ) | 350 708 $ | 2026-07-31 |
| 2026-07-20 | 0 ( -.--% ) | - $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
| CODEXIS, INC. | Verkställande Direktör | 2025-11-07 |
| ARTIVA BIOTHERAPEUTICS, INC. | Direktör/Styrelseledamot | 2024-10-21 |
| Företag | Position | Slut |
|---|---|---|
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Direktör/Styrelseledamot | 2023-10-01 |
| ALLOGENE THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2023-04-28 |
| AMGEN INC. | Företagsledare/Principal | 2018-06-01 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Generell Rådgivare | 2006-01-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 7 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Codexis, Inc.
Codexis, Inc. Chemicals: SpecialtyProcess Industries Develops biocatalytic chemical processes | Process Industries |
The University of Manchester
The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Allogene Therapeutics, Inc.
Allogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immuno-oncology | Health Technology |
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. Pharmaceuticals: OtherHealth Technology Operates as a biotechnology company which develops natural killer cell-based therapies for patients suffering from autoimmune diseases and cancers | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån